SCHEMBL1721131

SCHEMBL1721131

O=C1[CH]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3348301 0.78
SCHEMBL3121766 0.75
SCHEMBL5323960 0.70
SCHEMBL290757 0.70
SCHEMBL1555131 0.67
SCHEMBL7178562 0.65 GSK3A (0.50)
SCHEMBL7638036 0.63
SCHEMBL6364430 0.60
SCHEMBL11376825 0.60 TRIM24 (0.31)
SCHEMBL133712 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230372310-A1 Flavi-Block: A Pan-Flavivirus Inhibitor BADEN-WÜRTTEMBERG STIFTUNG GMBH (DE) 2023-11-23 US claimed
EP-4228631-A1 FLAVI-BLOCK: A PAN-FLAVIVIRUS INHIBITOR Baden-Württemberg Stiftung gGmbH (DE) 2023-08-23 EP claimed
US-20230219978-A1 COMPOUND HAVING MACROCYCLIC STRUCTURE AND USE THEREOF SCINNOHUB PHARMACEUTICAL CO., LTD (CN) 2023-07-13 US claimed
EP-4163283-A1 COMPOUND HAVING MACROCYCLIC STRUCTURE AND USE THEREOF Scinnohub Pharmaceutical Co., Ltd (CN) 2023-04-12 EP claimed
CN-113754682-B Compound having macrocyclic structure and use thereof 赛诺哈勃药业(成都)有限公司 2023-01-06 CN claimed
WO-2022078602-A1 FLAVI-BLOCK: A PAN-FLAVIVIRUS INHIBITOR BADEN-WÜRTTEMBERG STIFTUNG GGMBH (DE) 2022-04-21 WO claimed
CN-110407839-B Preparation and application of triazole heterocyclic compound containing heteroaryl amide structure 江西科技师范大学 2022-01-04 CN claimed
CN-113754682-A Compounds having macrocyclic structure and uses thereof 成都倍特药业股份有限公司 2021-12-07 CN claimed
WO-2021104529-A1 MACROLIDE BREFELDIN A ESTER DERIVATIVE, AND USE 中国海洋大学 2021-06-03 WO claimed
US-20190194166-A1 SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-06-27 US claimed
EP-0793499-A1 METHOD AND COMPOSITION FOR REDUCING TUMOR DEVELOPMENT WITH A COMBINATION OF A TAXANE COMPOUND AND A TELLURIUM AND/OR SELENIUM COMPOUND BAKER NORTON PHARMACEUTICALS, INC. (US) 1997-09-10 EP claimed
US-5648486-A LIPOXYGENASE INHIBITORS CYTOMED, INC. (US) 1997-07-15 US claimed
US-5530141-A REDUCES THE CHEMOTAXIS AND RESPIRATORY BURST LEADING TO THE FORMATION OF DAMAGING OXYGEN RADICAL DURING INFLAMMATORY AND IMMUNE RESPONSE CENTER FOR INNOVATIVE TECHNOLOGY (US) 1996-06-25 US claimed
WO-1996018401-A1 METHOD AND COMPOSITION FOR REDUCING TUMOR DEVELOPMENT WITH A COMBINATION OF A TAXANE COMPOUND AND A TELLURIUM AND/OR SELENIUM COMPOUND BAKER NORTON PHARMACEUTICALS, INC. (US) 1996-06-20 WO claimed
US-5434151-A Treatment of immune and inflammatory disorders, aryl substituted tetrahydrofurans, tetrahydrothiophenes, cyclopentanes, pyrrolidines CYTOMED, INC. (US) 1995-07-18 US claimed
US-5384066-A Free of nitriles, high holding ration (HR), liquid crystals MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1995-01-24 US claimed
US-5360711-A COLORFASTNESS, RESISTANCE TO DISCOLORATION FUJI PHOTO FILM CO., LTD. (JP) 1994-11-01 US claimed
US-5358938-A 2,5-Diaryl tetrahydrofurans, tetrahydrothiophenes, 1,3-cyclo-pentanes and pyrrolidines CYTOMED, INC. (US) 1994-10-25 US claimed
EP-0400971-A2 Method for preparation of taxol FLORIDA STATE UNIVERSITY (US) 1990-12-05 EP claimed
EP-0365089-A2 2-Aryl-5(3-methoxy-5-(hydroxypropylsulfonyl)-4-propoxyphenyl) tetrahydrothiophen and analogs MERCK & CO. INC. (US) 1990-04-25 EP claimed